| Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ... Annals of surgery 261 (1), 12-17, 2015 | 847 | 2015 |
| PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma F Sabbatino, V Villani, JH Yearley, V Deshpande, L Cai, IT Konstantinidis, ... Clinical Cancer Research 22 (2), 470-478, 2016 | 195 | 2016 |
| Genetic evolution of T-cell resistance in the course of melanoma progression A Sucker, F Zhao, B Real, C Heeke, N Bielefeld, S Maβen, S Horn, I Moll, ... Clinical Cancer Research 20 (24), 6593-6604, 2014 | 182 | 2014 |
| Epigenetic control of gene expression: Potential implications for cancer treatment F Perri, F Longo, M Giuliano, F Sabbatino, G Favia, F Ionna, R Addeo, ... Critical reviews in oncology/hematology 111, 166-172, 2017 | 145 | 2017 |
| Ipilimumab in the treatment of metastatic melanoma: management of adverse events G Della Vittoria Scarpati, C Fusciello, F Perri, F Sabbatino, S Ferrone, ... OncoTargets and therapy, 203-209, 2014 | 121 | 2014 |
| Blocking the formation of radiation–induced breast cancer stem cells Y Wang, W Li, SS Patel, J Cong, N Zhang, F Sabbatino, X Liu, Y Qi, ... Oncotarget 5 (11), 3743, 2014 | 118 | 2014 |
| COX-2 expression positively correlates with PD-L1 expression in human melanoma cells G Botti, F Fratangelo, M Cerrone, G Liguori, M Cantile, AM Anniciello, ... Journal of Translational Medicine 15, 1-12, 2017 | 98 | 2017 |
| The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology CR Ferrone, DT Ting, M Shahid, IT Konstantinidis, F Sabbatino, L Goyal, ... Annals of surgical oncology 23, 290-296, 2016 | 97 | 2016 |
| Role of human leukocyte antigen system as a predictive biomarker for checkpoint-based immunotherapy in cancer patients F Sabbatino, L Liguori, G Polcaro, I Salvato, G Caramori, FA Salzano, ... International journal of molecular sciences 21 (19), 7295, 2020 | 69 | 2020 |
| PD-L1 dysregulation in COVID-19 patients F Sabbatino, V Conti, G Franci, C Sellitto, V Manzo, P Pagliano, ... Frontiers in immunology 12, 695242, 2021 | 68 | 2021 |
| PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation F Sabbatino, Y Wang, X Wang, KT Flaherty, L Yu, D Pepin, S Pepe, ... Oncotarget 5 (7), 1926, 2014 | 67 | 2014 |
| A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram J Cong, Y Wang, X Zhang, N Zhang, L Liu, K Soukup, T Michelakos, ... Cancer letters 409, 9-19, 2017 | 62 | 2017 |
| Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 JM Fauci, F Sabbatino, YY Wang, AI Londoño-Joshi, JM Straughn Jr, ... Gynecologic oncology 132 (1), 203-210, 2014 | 57 | 2014 |
| Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy T Michelakos, L Cai, V Villani, F Sabbatino, F Kontos, ... JNCI: Journal of the National Cancer Institute 113 (2), 182-191, 2021 | 56 | 2021 |
| Enhanced expression of CD47 is associated with off-target resistance to tyrosine kinase inhibitor gefitinib in NSCLC A Nigro, L Ricciardi, I Salvato, F Sabbatino, M Vitale, MA Crescenzi, ... Frontiers in immunology 10, 3135, 2020 | 48 | 2020 |
| Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature F Sabbatino, A Marra, L Liguori, G Scognamiglio, C Fusciello, G Botti, ... Journal for immunotherapy of cancer 6, 1-8, 2018 | 46 | 2018 |
| Antitumor activity of BRAF inhibitor and IFNα combination in BRAF-mutant melanoma F Sabbatino, Y Wang, G Scognamiglio, E Favoino, SA Feldman, V Villani, ... Journal of the National Cancer Institute 108 (7), djv435, 2016 | 42 | 2016 |
| HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors R Sottile, PN Pangigadde, T Tan, A Anichini, F Sabbatino, F Trecroci, ... European journal of immunology 46 (2), 409-419, 2016 | 41 | 2016 |
| Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells CY Tsao, F Sabbatino, NKV Cheung, JC Hsu, V Villani, X Wang, ... Oncoimmunology 4 (8), e1023975, 2015 | 37 | 2015 |
| Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients F Sabbatino, V Conti, L Liguori, G Polcaro, G Corbi, V Manzo, V Tortora, ... Life 11 (2), 105, 2021 | 35 | 2021 |
